Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma

Major Program(s) or Research Group(s)

  • Gastrointestinal and Other Cancers
  • Phase 0/I/II Cancer Prevention Clinical Trials Program

Sponsor

National Cancer Institute (NCI)

Status

Recruiting

ClinicalTrials.gov ID

For more information, see ClinicalTrials.gov NCT02965703

This phase IIa trial studies how well aspirin works in preventing colorectal cancer in
patients with colorectal adenoma. Aspirin may stop the growth of tumor cells by blocking some
of the enzymes needed for cell growth.

Intervention

Aspirin, Laboratory Biomarker Analysis, Questionnaire Administration, Placebo Administration

Condition

Colorectal Adenoma

Investigators

Qi Dai

See list of participating sites